Amicus Therapeutics Inc. buy Morgan Stanley
Start price
19.12.23
/
50%
€12.00
Target price
19.12.24
€18.24
Performance (%)
-20.00%
Price
25.07.24
€9.45
Summary
This prediction is currently active. The price of Amicus Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.00%. This prediction currently runs until 19.12.24. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amicus Therapeutics Inc. | -2.604% | -2.604% |
iShares Core DAX® | 0.039% | 0.567% |
iShares Nasdaq 100 | -4.018% | -5.554% |
iShares Nikkei 225® | -2.389% | -1.434% |
iShares S&P 500 | -2.115% | -2.351% |
Comments by Morgan_Stanley for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $15.00.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by Morgan_Stanley for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.60
10.05.24
10.05.24
€17.64
10.05.25
10.05.25
11.63%
25.07.24
25.07.24